AWARENESS
The general public doesn’t realize the magnitude of problems faced by children and adolescents with cancer and those who survive their cancers. The Awareness Interest Group seeks to shine the spotlight on facts, such as:
- Childhood cancer is the leading cause of death by disease among children and adolescents in the United States.
- Most causes of childhood cancer are unknown and not preventable.
- The incidence of childhood cancer is on the increase.
- Most survivors will experience significant debilitating complications that result from their treatment regimes.
- Children and adolescents who have or have had cancer are much more likely (more than 60%) to face bullying than their healthy classmates.
- Only four drugs have been developed and approved to treat a pediatric cancer in the last quarter century.
CAC2 member organizations with an interest in Awareness are encouraged to participate in the work of the CAC2 Advocacy and Awareness Interest Group. Notes from the 2019 meeting of the working group are available here. Email if you would like more information on how to be involved with CAC2 awareness initiatives.
Raising awareness is crucial to increasing research funds and legislative efficacy.
Collaborating amplifies our impact.
Latest CAC2 and Community News

CAC2 Childhood Cancer Community News Digest (April 21-27)
Assorted News from the Last Week: Parents of kids with cancer fear GOP budget cuts could slash Medicaid What I wish I had known: A pediatric oncologist's transition to survivorship care The Food and Drug Administration (FDA) has granted breakthrough ...

CAC2 Childhood Cancer Community News Digest (April 14-20)
Assorted News from the Last Week: CAC2 Individual Member Robert Dilley blogging about why sustained research funding is essential to progress. AACR issues calls to action to advocacy colleagues and supporters of NIH funding. NCI Annual Report to the Nation: ...

CAC2 Childhood Cancer Community News Digest (April 7-13)
Assorted News from the Last Week: A study explores the effects of identifying pediatric cancer survivors at risk for complications, developing targeted interventions, determining where and how to provide life-long risk-based care, and whether providing risk-based surveillance will mitigate the ...